Picture of Gencurix logo

229000 Gencurix Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Gencurix, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,5723,0472,5592,6005,134
Cost of Revenue
Gross Profit-1,250-2,9781,1581,3483,778
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses9,65315,51416,71413,7467,833
Operating Profit-8,081-12,467-14,154-11,146-2,699
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes32,966-35,150-25,452-20,295-4,137
Provision for Income Taxes
Net Income After Taxes32,964-35,149-25,451-20,139-4,148
Minority Interest
Net Income Before Extraordinary Items
Net Income33,108-34,670-24,597-19,260-3,626
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income33,108-34,670-24,597-19,260-3,626
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS4,910-4,866-3,099-1,625-501
Dividends per Share